Inventor · disambiguated record
Dennis M. Brown
Also filed as: BROWN DENNIS · BROWN DENNIS M · BROWN DENNIS MICHAEL
48 granted patents·68 pending applications·1,124 citations·filing 1985–2025
98Inventor score
Files withBROWN DENNIS M16CHEMGENEX PHARMACEUTICALS INC14DELMAR PHARMACEUTICALS INC11DEL MAR PHARMACEUTICALS BC LTD9MASSACHUSETTS GEN HOSPITAL9
Top patents by PatentIndex Score
116 records- 0197US10304669B1Adaptive counter measure control thwarting IMD jamming impairments for RF plasma systemsMKS INSTR INC·Filed 2018·Granted May 28, 2019·56 cites·35 claims
- 0296US4619913ATreatments employing drug-containing matrices for introduction into cellular lesion areasMATRIX PHARMA INC·Filed 1985·Granted Oct 28, 1986·158 cites·12 claims
- 0395US10229816B2Solid-state impedance matching systems including a hybrid tuning network with a switchable coarse tuning network and a varactor fine tuning networkMKS INSTR INC·Filed 2016·Granted Mar 12, 2019·17 cites·43 claims
- 0494US5290552ASurgical adhesive materialMATRIX PHARMACEUTICAL INC PROJ·Filed 1992·Granted Mar 1, 1994·441 cites·21 claims
- 0590US5573781AMethods and compositions for the treatment of a host with a cellular proliferative diseaseMATRIX PHARMA·Filed 1994·Granted Nov 12, 1996·104 cites·36 claims
- 0688US7748529B2Surgical instrument caseSYMMETRY MEDICAL INC·Filed 2006·Granted Jul 6, 2010·30 cites·15 claims
- 0787US6734178B2Cephalotaxine alkaloid compositions and uses thereofCHEMGENEX THERAPEUTICS INC·Filed 2001·Granted May 11, 2004·19 cites·10 claims
- 0886US6630173B2Naphthalimide compositions and uses thereofCHEMGENEX THERAPEUTICS INC·Filed 2001·Granted Oct 7, 2003·18 cites·9 claims
- 0985US9901563B2Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Feb 27, 2018·2 cites·10 claims
- 1085US7683050B2Formulations and methods of administration of cephalotaxines, including homoharringtonineCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Granted Mar 23, 2010·3 cites·14 claims
- 1185US4978332ATreatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areasMATRIX PHARMA·Filed 1987·Granted Dec 18, 1990·75 cites·20 claims
- 1282US9066918B2Methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolBROWN DENNIS M·Filed 2011·Granted Jun 30, 2015·6 cites·41 claims
- 1382US8563758B2Method of synthesis of substituted hexitols such as dianhydrogalactitolBROWN DENNIS M·Filed 2011·Granted Oct 22, 2013·3 cites·20 claims
- 1482US5597578ATGF-β protein compositions for inhibition of cell proliferationONCOGEN·Filed 1994·Granted Jan 28, 1997·65 cites·14 claims
- 1581US9687466B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiformeDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·5 cites·42 claims
- 1679US12336993B2Therapeutic benefit of suboptimally administered chemical compoundsBROWN DENNIS M·Filed 2022·Granted Jun 24, 2025·0 cites·7 claims
- 1779US11717505B2Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Granted Aug 8, 2023·1 cites·11 claims
- 1878US2025312347A1Therapeutic benefit of suboptimally administered chemical compoundsBROWN DENNIS M·Filed 2025·Application pending·0 cites
- 1976US2022193024A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 2075US2022142966A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 2174US9041480B2Virtual RF sensorMKS INSTR INC·Filed 2013·Granted May 26, 2015·4 cites·20 claims
- 2272US11234955B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2019·Granted Feb 1, 2022·0 cites·7 claims
- 2372US9814693B2Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignanciesDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Nov 14, 2017·2 cites·5 claims
- 2471US11719711B2Compositions and methods for detecting and/or treating inflammationMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Aug 8, 2023·0 cites·17 claims
- 2571US11446274B2Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2016·Granted Sep 20, 2022·1 cites·4 claims
- 2671US10201521B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2013·Granted Feb 12, 2019·1 cites·6 claims
- 2769US11491154B2Therapeutic benefit of suboptimally administered chemical compoundsBROWN DENNIS M·Filed 2014·Granted Nov 8, 2022·0 cites·2 claims
- 2869US2023338325A1Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2023·Application pending·0 cites
- 2968US10935556B2Compositions and methods for detecting and/or treating inflammationMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Mar 2, 2021·0 cites·13 claims
- 3067US2011053157A1Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditionsGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 3166US4910227AHigh volumetric production of methanol in a liquid phase reactorAIR PROD & CHEM·Filed 1988·Granted Mar 20, 1990·17 cites·11 claims
- 3265US10383847B2Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigoBROWN DENNIS M·Filed 2014·Granted Aug 20, 2019·1 cites·2 claims
- 3365US4801574AIn-situ activation of CuO/ZnO/Al2 O3 catalysts in the liquid phaseAIR PROD & CHEM·Filed 1987·Granted Jan 31, 1989·20 cites·3 claims
- 3465US2007207977A1Naphthalimide compositions and uses thereofBROWN DENNIS M·Filed 2007·Application pending·0 cites
- 3564US2012058991A1Formulations and Methods of Administration of Cephalotaxines, Including HomoharringtonineBROWN DENNIS M·Filed 2011·Application pending·0 cites
- 3664US2014194319A1Use of microvesicles in diagnosis and prognosis of medical diseases and conditionsGEN HOSPITAL CORP·Filed 2014·Application pending·0 cites
- 3763US7642252B2Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2003·Granted Jan 5, 2010·1 cites·22 claims
- 3863US2020206188A1Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigoBROWN DENNIS M·Filed 2019·Application pending·0 cites
- 3963US2017314075A1Use of microvesicles in diagnosis and prognosis of medical diseases and conditionsMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 4063US2012207855A1Cephalotaxine alkaloid compositions and uses thereofBROWN DENNIS M·Filed 2011·Application pending·0 cites
- 4162US11026914B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumorDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jun 8, 2021·1 cites·8 claims
- 4262US2014194613A1Use of microvesicles in diagnosis and prognosis of medical diseases and conditionsGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 4362US2021251944A1Methods for treating a cancer resistant to at least one tyrosine kinase inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2021·Application pending·0 cites
- 4461US9891236B2Compositions and methods for detecting and/or treating inflammationMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Feb 13, 2018·0 cites·19 claims
- 4561US7135481B2Naphthalimide compositions and uses thereofCHEMGENEX PHARMACEUTICALS INC·Filed 2005·Granted Nov 14, 2006·0 cites·13 claims
- 4661US2013131194A1Use of microvesicles in diagnosis and prognosis of medical diseases and conditionsGEN HOSPITAL CORP·Filed 2012·Application pending·0 cites
- 4761US2018051335A9Use of microvesicles in diagnosis and prognosis of medical diseases and conditionsMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 4861US2024307372A1Compositions and methods to improve benefit of suboptimally administered therapeuctics for the treatment of benign and neoplastic diseases, infections, inflammatory, metabolic and immunologial diseasesESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4961US2024307373A1Methods of use and compositions of bisbenzylisoquinolines for the treatment of malignanciesESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 5061US2024342161A1Bisbenzylisoquinolines as conditioning agents for immune therapyESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 116 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dennis M. Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →